Suchergebnisse - "Saif, Muhammad Wasif"

PubPharm (25)

1

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Saif, M. | Knost, J. | Chiorean, E. | +6

2

Novel agents for the treatment of pancreatic cancer

enthalten in: JOP : Journal of the pancreas | 2014

von Brennan, G. | Relias, V. | Saif, M.

3

Novel agents and future prospects in the treatment of pancreatic adenocarcinoma

enthalten in: JOP : Journal of the pancreas | 2013

von Sarris, E. | Syrigos, K. | Saif, M.

4

Novel agents in the treatment of pancreatic adenocarcinoma

enthalten in: JOP : Journal of the pancreas | 2013

von Dimou, A. | Syrigos, K. | Saif, M.

5

Novel agents in early phase clinical studies on refractory pancreatic cancer

enthalten in: JOP : Journal of the pancreas | 2012

von Strimpakos, A. | Syrigos, K. | Saif, M.

6

Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome : cumulative toxicity of an old drug in a new era

enthalten in: Clinical colorectal cancer | 2011

von El-Ghazal, R. | Podoltsev, N. | Marks, P. | +2

7

Novel agents in the management of pancreatic adenocarcinoma : phase I studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011

enthalten in: JOP : Journal of the pancreas | 2011

von Dimou, A. | Syrigos, K. | Saif, M.

8

Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011

enthalten in: JOP : Journal of the pancreas | 2011

von Strimpakos, A. | Syrigos, K. | Saif, M.

9

Safety and efficacy of panitumumab therapy after progression with cetuximab : experience at two institutions

enthalten in: Clinical colorectal cancer | 2010

von Saif, M. | Kaley, K. | Chu, E. | +1

10

Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2010

von Reidy, D. | Vakiani, E. | Fakih, M. | +11